ARMATA PHARMACEUTICALS, INC. Investment Income, Interest
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Investment Income, Interest of $221.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2024-08-13
- ARMATA PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2024-06-30 was $221.00K, a 380.43% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2024-03-31 was $52.00K, a 188.89% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2023-12-31 was $68.00K, a 385.71% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2023-09-30 was $47.00K, a 422.22% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. investment income, interest for fiscal 2023 was $179.00K, a 517.24% increase from fiscal 2022.
- ARMATA PHARMACEUTICALS, INC. investment income, interest for fiscal 2022 was $29.00K, a 480.00% increase from fiscal 2021.
- ARMATA PHARMACEUTICALS, INC. investment income, interest for fiscal 2021 was $5.00K, a 82.14% decline from fiscal 2020.
- ARMATA PHARMACEUTICALS, INC. investment income, interest for fiscal 2020 was $28.00K, a 70.83% decline from fiscal 2019.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2024-06-30 | $221.00K 10-Q · filed 2024-08-13 | $273.00K 10-Q · filed 2024-08-13 | $341.00K derived: sum of 3 quarters · filed 2024-08-13 | $388.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | $52.00K 10-Q · filed 2024-05-07 | $120.00K derived: sum of 2 quarters · filed 2024-05-07 | $167.00K derived: sum of 3 quarters · filed 2024-05-07 | $213.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $115.00K derived: sum of 2 quarters · filed 2024-03-21 | $161.00K derived: sum of 3 quarters · filed 2024-08-13 | $179.00K 10-K · filed 2024-03-21 |
| 2023-09-30 | $47.00K 10-Q · filed 2023-11-14 | $93.00K derived: sum of 2 quarters · filed 2024-08-13 | $111.00K 10-Q · filed 2023-11-14 | $125.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-06-30 | $46.00K 10-Q · filed 2024-08-13 | $64.00K 10-Q · filed 2024-08-13 | $78.00K derived: sum of 3 quarters · filed 2024-08-13 | $87.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $18.00K 10-Q · filed 2024-05-07 | $32.00K derived: sum of 2 quarters · filed 2024-05-07 | $41.00K derived: sum of 3 quarters · filed 2024-05-07 | $46.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $23.00K derived: sum of 2 quarters · filed 2024-03-21 | $28.00K derived: sum of 3 quarters · filed 2024-03-21 | $29.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $9.00K 10-Q · filed 2023-11-14 | $14.00K derived: sum of 2 quarters · filed 2023-11-14 | $15.00K 10-Q · filed 2023-11-14 | $16.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $5.00K 10-Q · filed 2023-08-14 | $6.00K 10-Q · filed 2023-08-14 | $7.00K derived: sum of 3 quarters · filed 2023-08-14 | $7.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-11 | $2.00K derived: sum of 2 quarters · filed 2023-05-11 | $2.00K derived: sum of 3 quarters · filed 2023-05-11 | $4.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.00K derived: sum of 2 quarters · filed 2023-03-16 | $3.00K derived: sum of 3 quarters · filed 2023-03-16 | $5.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.00K derived: sum of 2 quarters · filed 2022-11-09 | $4.00K 10-Q · filed 2022-11-09 | $4.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.00K 10-Q · filed 2022-08-11 | $4.00K 10-Q · filed 2022-08-11 | $4.00K derived: sum of 3 quarters · filed 2022-08-11 | $8.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-12 | $2.00K derived: sum of 2 quarters · filed 2022-05-12 | $6.00K derived: sum of 3 quarters · filed 2022-05-12 | $28.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $4.00K derived: sum of 2 quarters · filed 2022-03-17 | $26.00K derived: sum of 3 quarters · filed 2022-03-17 | $28.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $4.00K 10-Q · filed 2021-11-10 | $26.00K derived: sum of 2 quarters · filed 2021-11-10 | $28.00K 10-Q · filed 2021-11-10 | $35.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $22.00K 10-Q · filed 2021-08-12 | $24.00K 10-Q · filed 2021-08-12 | $31.00K derived: sum of 3 quarters · filed 2021-08-12 | $44.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-13 | $9.00K derived: sum of 2 quarters · filed 2021-05-13 | $22.00K derived: sum of 3 quarters · filed 2021-05-13 | $50.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $20.00K derived: sum of 2 quarters · filed 2021-03-18 | $48.00K derived: sum of 3 quarters · filed 2021-03-18 | $96.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $13.00K 10-Q · filed 2020-11-12 | $41.00K derived: sum of 2 quarters · filed 2020-11-12 | $89.00K 10-Q · filed 2020-11-12 | $154.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $28.00K 10-Q · filed 2020-08-13 | $76.00K 10-Q · filed 2020-08-13 | $141.00K derived: sum of 3 quarters · filed 2020-08-13 | $211.00K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $48.00K 10-Q · filed 2020-05-14 | $113.00K derived: sum of 2 quarters · filed 2020-05-14 | $183.00K derived: sum of 3 quarters · filed 2020-05-14 | $241.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $135.00K derived: sum of 2 quarters · filed 2020-03-19 | $193.00K derived: sum of 3 quarters · filed 2020-03-19 | $245.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | $70.00K 10-Q · filed 2019-11-12 | $128.00K derived: sum of 2 quarters · filed 2019-11-12 | $180.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $58.00K 10-Q · filed 2019-08-14 | $110.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |